Prognostic implications of combined high expression of CD47 and MCT1 in breast cancer: a retrospective study during a 10-year period

BACKGROUND: Clinical outcome after surgery of breast cancer needs more prognostic markers to predict currently. Cluster of differentiation 47 (CD47), due to its overexpression in various tumors and ability to inhibit phagocytosis, has been identified as a new immune checkpoint. Monocarboxylate trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yanting, Liang, Shujing, Li, Tong, Peng, Chujie, Yang, Yiting, Lin, Yun, Ma, Yabin, Dong, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841544/
https://www.ncbi.nlm.nih.gov/pubmed/35261882
http://dx.doi.org/10.21037/tcr-21-1951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841544/
https://www.ncbi.nlm.nih.gov/pubmed/35261882
http://dx.doi.org/10.21037/tcr-21-1951

Ejemplares similares